Hospital Tumor Marker Market: An Overview The hospital tumor market is riding a promising wave as rising awareness about cancer illnesses, and increased attempt to detect cancers at early stages to provide best possible care becomes the gold standard in healthcare. The hospital tumor marker market is a fragmented and competitive landscape, with several manufacturers specialising in wide varieties of tumor markers for detection. Additionally, the bars of entry continue to remain low or non-existent perhaps as technical know-how of marker manufacturing becomes a widely standardised practice. Hence, the market is home to a large number of small and large number of manufacturers, wherein large players like Abbott Laboratories, Applied Genetic Technologies Corporation, Becton, Dickinson and Company, Biomedical Diagnostics, among others continue to provide FDA approved, and proprietary standards for cancer detection, and treatment follow-up solutions. The distribution of the hospital...
Today, healthcare organizations operate in a dynamic ecosystem, wherein they are required to adopt unprecedented advancements for diagnostics and therapeutics, every now and then. Healthcare organizations are facing the uphill task to incorporate technological driven processes, and deliver managed care to the discerning consumer.